Beijing Tong Ren Tang Chinese Medicine Company Limited
HKSE: 3613.HK0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Hong Kong Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Wang Chi
- Employees
- 782
- Headquarters
- Wan Chai, Hong Kong SAR China
- IPO year
- 2013
- Market cap
- HK$6.2B
- Website
- https://www.tongrentangcm.com
Loading 3613…
Loading profile data…Frequently asked questions about 3613
What does Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) do?
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and...
Where does 3613.HK trade?
Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) trades on the Hong Kong Stock Exchange.
What sector is 3613.HK in?
Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Beijing Tong Ren Tang Chinese Medicine Company Limited?
Wang Chi is the chief executive officer of Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK).
Where is Beijing Tong Ren Tang Chinese Medicine Company Limited headquartered?
Beijing Tong Ren Tang Chinese Medicine Company Limited is headquartered in Hong Kong SAR China.
Does 3613.HK pay a dividend?
Yes — Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) paid a trailing twelve-month dividend of HKD 0.35 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 3613.HK go public?
Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) completed its initial public offering in 2013.